Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Desensitization, Immunologic | 9 | 2019 | 574 | 2.41 | Why? |
| Immune Tolerance | 9 | 2019 | 608 | 1.79 | Why? |
| Allergens | 11 | 2019 | 728 | 1.75 | Why? |
| Hypersensitivity | 14 | 2021 | 1137 | 1.36 | Why? |
| B-Lymphocytes, Regulatory | 4 | 2018 | 24 | 1.30 | Why? |
| Asthma | 13 | 2020 | 4383 | 0.91 | Why? |
| T-Lymphocytes, Regulatory | 4 | 2019 | 698 | 0.79 | Why? |
| Rhinitis, Allergic | 4 | 2020 | 704 | 0.78 | Why? |
| Tight Junctions | 4 | 2019 | 179 | 0.66 | Why? |
| Dermatitis, Atopic | 1 | 2019 | 714 | 0.43 | Why? |
| Sublingual Immunotherapy | 3 | 2020 | 88 | 0.41 | Why? |
| Palatine Tonsil | 4 | 2018 | 127 | 0.39 | Why? |
| B-Lymphocytes | 3 | 2019 | 4418 | 0.35 | Why? |
| Biological Products | 2 | 2020 | 2331 | 0.34 | Why? |
| Respiratory Hypersensitivity | 1 | 2008 | 103 | 0.33 | Why? |
| Immunoglobulin E | 6 | 2020 | 557 | 0.33 | Why? |
| Interleukin-13 | 2 | 2019 | 204 | 0.33 | Why? |
| Rhinitis | 3 | 2018 | 626 | 0.32 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.30 | Why? |
| Nasal Polyps | 2 | 2018 | 221 | 0.29 | Why? |
| Interleukin-10 | 3 | 2018 | 1409 | 0.27 | Why? |
| Inhalation Exposure | 1 | 2008 | 405 | 0.26 | Why? |
| Immunologic Factors | 2 | 2018 | 4206 | 0.25 | Why? |
| Rhinovirus | 2 | 2018 | 979 | 0.24 | Why? |
| T-Lymphocyte Subsets | 2 | 2017 | 1387 | 0.23 | Why? |
| Lymphocyte Subsets | 2 | 2019 | 987 | 0.22 | Why? |
| Sinusitis | 2 | 2018 | 649 | 0.21 | Why? |
| Mast Cells | 2 | 2017 | 370 | 0.20 | Why? |
| Immunity, Innate | 6 | 2020 | 6570 | 0.19 | Why? |
| Arthropod Venoms | 1 | 2018 | 27 | 0.19 | Why? |
| Paranasal Sinuses | 2 | 2019 | 217 | 0.19 | Why? |
| Injections, Subcutaneous | 2 | 2018 | 647 | 0.19 | Why? |
| Receptor, Cannabinoid, CB1 | 1 | 2018 | 12 | 0.19 | Why? |
| Th2 Cells | 2 | 2020 | 680 | 0.18 | Why? |
| Keratinocytes | 1 | 2019 | 119 | 0.18 | Why? |
| Lymphocytes | 4 | 2020 | 3056 | 0.18 | Why? |
| DNA, Catalytic | 1 | 2018 | 48 | 0.18 | Why? |
| Tretinoin | 1 | 2019 | 99 | 0.18 | Why? |
| Detergents | 1 | 2018 | 107 | 0.18 | Why? |
| Neuraminic Acids | 1 | 2017 | 18 | 0.18 | Why? |
| Immunologic Techniques | 1 | 2017 | 71 | 0.17 | Why? |
| Dronabinol | 1 | 2018 | 89 | 0.17 | Why? |
| Hydrazines | 1 | 2018 | 68 | 0.17 | Why? |
| CTLA-4 Antigen | 1 | 2018 | 282 | 0.16 | Why? |
| Vitamin E | 1 | 2017 | 128 | 0.16 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2017 | 159 | 0.15 | Why? |
| Vitamin A | 1 | 2017 | 188 | 0.15 | Why? |
| Colitis | 1 | 2017 | 266 | 0.13 | Why? |
| Farmers | 1 | 2017 | 280 | 0.13 | Why? |
| Fluorescent Dyes | 1 | 2018 | 536 | 0.13 | Why? |
| Forkhead Transcription Factors | 2 | 2017 | 231 | 0.13 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.13 | Why? |
| Eosinophils | 3 | 2020 | 848 | 0.12 | Why? |
| Food Hypersensitivity | 1 | 2018 | 397 | 0.12 | Why? |
| Animals | 12 | 2020 | 78931 | 0.12 | Why? |
| Flow Cytometry | 2 | 2018 | 2393 | 0.12 | Why? |
| Vaccines | 2 | 2021 | 3692 | 0.12 | Why? |
| Bronchi | 1 | 2018 | 1048 | 0.11 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| T-Lymphocytes | 3 | 2018 | 6670 | 0.11 | Why? |
| Immunomodulation | 2 | 2017 | 1472 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| Core Binding Factor Alpha 3 Subunit | 1 | 2009 | 9 | 0.11 | Why? |
| Alveolar Epithelial Cells | 1 | 2018 | 1445 | 0.10 | Why? |
| Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 40 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Environmental Exposure | 2 | 2017 | 1558 | 0.10 | Why? |
| Dendritic Cells | 1 | 2018 | 1330 | 0.10 | Why? |
| Transforming Growth Factor beta | 2 | 2009 | 363 | 0.10 | Why? |
| Histamine Release | 1 | 2008 | 9 | 0.10 | Why? |
| Humans | 41 | 2021 | 930598 | 0.10 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.09 | Why? |
| T-Cell Antigen Receptor Specificity | 1 | 2008 | 93 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Respiratory Mucosa | 1 | 2017 | 1522 | 0.09 | Why? |
| Basophils | 1 | 2008 | 179 | 0.09 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.09 | Why? |
| Phenotype | 4 | 2020 | 4037 | 0.08 | Why? |
| Academies and Institutes | 2 | 2020 | 539 | 0.08 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2008 | 593 | 0.08 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2019 | 4849 | 0.07 | Why? |
| Precision Medicine | 3 | 2020 | 1477 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Biomarkers | 7 | 2020 | 23361 | 0.06 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2019 | 6153 | 0.05 | Why? |
| Major Histocompatibility Complex | 1 | 2018 | 70 | 0.05 | Why? |
| Allergists | 1 | 2020 | 266 | 0.05 | Why? |
| Mice, Knockout | 2 | 2017 | 1815 | 0.05 | Why? |
| Precursor Cells, B-Lymphoid | 1 | 2017 | 12 | 0.05 | Why? |
| Receptors, Histamine H2 | 1 | 2017 | 9 | 0.04 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.04 | Why? |
| Gene-Environment Interaction | 1 | 2018 | 127 | 0.04 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.04 | Why? |
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 24 | 0.04 | Why? |
| CD40 Ligand | 1 | 2017 | 121 | 0.04 | Why? |
| Histamine | 1 | 2017 | 61 | 0.04 | Why? |
| Alarmins | 1 | 2018 | 180 | 0.04 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.04 | Why? |
| Cytokines | 4 | 2020 | 15010 | 0.04 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.04 | Why? |
| Economics, Pharmaceutical | 1 | 2016 | 61 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Hypersensitivity, Immediate | 1 | 2017 | 134 | 0.04 | Why? |
| Cell Separation | 1 | 2017 | 270 | 0.04 | Why? |
| Autoantigens | 1 | 2018 | 388 | 0.04 | Why? |
| Tonsillectomy | 1 | 2017 | 115 | 0.04 | Why? |
| Epithelial Cells | 2 | 2019 | 3508 | 0.04 | Why? |
| Mucus | 1 | 2017 | 183 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2018 | 4020 | 0.04 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.04 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Dysbiosis | 1 | 2020 | 685 | 0.03 | Why? |
| Child | 6 | 2020 | 70012 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2018 | 572 | 0.03 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.03 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Interleukin-1 | 1 | 2017 | 438 | 0.03 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Common Cold | 1 | 2018 | 645 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.03 | Why? |
| False Positive Reactions | 1 | 2017 | 1338 | 0.03 | Why? |
| Female | 8 | 2020 | 380317 | 0.03 | Why? |
| Interleukin-17 | 1 | 2017 | 602 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Autoimmunity | 1 | 2018 | 841 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Mice | 3 | 2017 | 21357 | 0.03 | Why? |
| Core Binding Factor beta Subunit | 1 | 2009 | 4 | 0.03 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.03 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2018 | 1995 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.02 | Why? |
| Probiotics | 1 | 2017 | 694 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2017 | 21571 | 0.02 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.02 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.02 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.02 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Gene Silencing | 1 | 2009 | 213 | 0.02 | Why? |
| Gene Expression | 1 | 2019 | 3332 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2019 | 5542 | 0.02 | Why? |
| Immune System | 1 | 2017 | 1479 | 0.02 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.02 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.02 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2016 | 2259 | 0.02 | Why? |
| Promoter Regions, Genetic | 1 | 2009 | 823 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Software | 1 | 2017 | 2501 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
| RNA, Small Interfering | 1 | 2009 | 817 | 0.02 | Why? |
| RNA, Messenger | 1 | 2019 | 5131 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.02 | Why? |
| Male | 6 | 2020 | 367725 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Consensus | 1 | 2016 | 6345 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Adult | 3 | 2020 | 244371 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Lung | 1 | 2019 | 31049 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |
Akdis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(265)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_